Page last updated: 2024-08-24

sematilide and Atrioventricular Nodal Re-Entrant Tachycardia

sematilide has been researched along with Atrioventricular Nodal Re-Entrant Tachycardia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cui, G; Sager, P; Sen, L; Singh, BN; Uppal, P1
Follmer, C; Godfrey, R; Pruitt, C; Sager, PT; Uppal, P1
Antimisiaris, M; Godfrey, R; Nademanee, K; Pacifico, A; Pruitt, C; Sager, PT; Singh, BN1

Trials

2 trial(s) available for sematilide and Atrioventricular Nodal Re-Entrant Tachycardia

ArticleYear
Effects of amiodarone, sematilide, and sotalol on QT dispersion.
    The American journal of cardiology, 1994, Nov-01, Volume: 74, Issue:9

    Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Follow-Up Studies; Heart Conduction System; Humans; Male; Middle Aged; Procainamide; Retrospective Studies; Sotalol; Tachycardia, Ventricular; Time Factors

1994
The effects of beta-adrenergic stimulation on the frequency-dependent electrophysiologic actions of amiodarone and sematilide in humans.
    Circulation, 1994, Volume: 90, Issue:4

    Topics: Action Potentials; Adrenergic beta-Agonists; Amiodarone; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Heart; Heart Conduction System; Humans; Isoproterenol; Middle Aged; Procainamide; Prospective Studies; Reaction Time; Refractory Period, Electrophysiological; Tachycardia, Ventricular; Ventricular Function

1994

Other Studies

1 other study(ies) available for sematilide and Atrioventricular Nodal Re-Entrant Tachycardia

ArticleYear
Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Circulation, 1993, Volume: 88, Issue:3

    Topics: Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Electrocardiography, Ambulatory; Heart Conduction System; Humans; Male; Middle Aged; Procainamide; Prospective Studies; Syncope; Tachycardia, Ventricular; Ventricular Fibrillation

1993